Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-16 11:20 am Sale |
2025-03-31 | 13G | Eli Lilly and Company LLY |
LILLY ENDOWMENT INC | 96,016,978 10.100% |
-875,000 (-0.90%) |
Filing History |
| 2025-02-07 08:52 am Sale |
2024-12-31 | 13G | Eli Lilly and Company LLY |
PNC FINANCIAL SERVICES GROUP INC. PNC |
51,153,837 5.390% |
-58,735 (-0.11%) |
Filing History |
| 2025-01-27 3:54 pm Unchanged |
2024-12-31 | 13G | Eli Lilly and Company LLY |
LILLY ENDOWMENT INC | 96,891,978 10.200% |
0 (Unchanged) |
Filing History |
| 2024-11-14 7:00 pm Sale |
2024-09-30 | 13G | Eli Lilly and Company LLY |
PNC FINANCIAL SERVICES GROUP INC. PNC |
51,212,572 5.390% |
-327,533 (-0.64%) |
Filing History |
| 2024-10-23 5:17 pm Sale |
2024-09-30 | 13G | Eli Lilly and Company LLY |
LILLY ENDOWMENT INC | 96,891,978 10.200% |
-2,876,832 (-2.88%) |
Filing History |
| 2024-02-13 5:04 pm Sale |
2023-12-29 | 13G | Eli Lilly and Company LLY |
The Vanguard Group | 71,604,696 7.540% |
-1,825,167 (-2.49%) |
Filing History |
| 2024-02-09 09:26 am Sale |
2023-12-31 | 13G | Eli Lilly and Company LLY |
PNC FINANCIAL SERVICES GROUP INC. PNC |
51,540,105 5.430% |
-289,768 (-0.56%) |
Filing History |
| 2024-01-29 3:26 pm Sale |
2023-12-31 | 13G | Eli Lilly and Company LLY |
BlackRock Inc. BLK |
64,376,027 6.800% |
-1,091,766 (-1.67%) |
Filing History |
| 2024-01-26 4:25 pm Sale |
2023-12-31 | 13G | Eli Lilly and Company LLY |
LILLY ENDOWMENT INC | 99,768,810 10.510% |
-3,180,000 (-3.09%) |
Filing History |
| 2023-08-14 4:30 pm Purchase |
2023-08-11 | 13D | Sigilon Therapeutics, Inc. SGTX |
ELI LILLY & Co LLY |
100 100.000% |
100 (New Position) |
Filing History |
| 2023-07-07 4:33 pm Purchase |
2023-06-28 | 13D | Sigilon Therapeutics, Inc. SGTX |
ELI LILLY & Co LLY |
1,008,830 40.300% |
797,719 (+377.87%) |
Filing History |
| 2023-02-10 10:42 am Sale |
2022-12-31 | 13G | Eli Lilly and Company LLY |
PNC FINANCIAL SERVICES GROUP INC. PNC |
51,829,873 5.250% |
-58,582 (-0.11%) |
Filing History |
| 2023-02-09 11:19 am Purchase |
2022-12-30 | 13G | Eli Lilly and Company LLY |
The Vanguard Group | 73,429,863 7.730% |
4,168,109 (+6.02%) |
Filing History |
| 2023-01-31 5:52 pm Purchase |
2022-12-31 | 13G | Eli Lilly and Company LLY |
BlackRock Inc. BLK |
65,467,793 6.900% |
1,590,770 (+2.49%) |
Filing History |
| 2023-01-27 4:57 pm Unchanged |
2022-12-31 | 13G | Precision BioSciences, Inc. DTIL |
ELI LILLY & Co LLY |
125,406 3.400% |
0 (Unchanged) |
Filing History |
| 2023-01-27 4:41 pm Unchanged |
2022-12-31 | 13G | AC Immune SA ACIU |
ELI LILLY & Co LLY |
3,615,328 4.300% |
0 (Unchanged) |
Filing History |
| 2023-01-25 4:14 pm Sale |
2022-12-31 | 13G | Eli Lilly and Company LLY |
LILLY ENDOWMENT INC | 102,948,810 10.830% |
-4,515,000 (-4.20%) |
Filing History |
| 2022-12-23 4:39 pm Purchase |
2022-12-21 | 13G | ProQR Therapeutics N.V. PRQR |
ELI LILLY & Co LLY |
13,371,562 16.600% |
9,381,586 (+235.13%) |
Filing History |
| 2022-12-01 4:11 pm Sale |
2022-11-30 | 13D | Akouos, Inc. AKUS |
ELI LILLY & Co LLY |
100 100.000% |
-9,639,089 (-100.00%) |
Filing History |
| 2022-10-27 4:31 pm Purchase |
2022-10-17 | 13D | Akouos, Inc. AKUS |
ELI LILLY & Co LLY |
9,639,189 25.500% |
9,639,189 (New Position) |
Filing History |